AAAAAA

   
Results: 1-10 |
Results: 10

Authors: BORK A BRITTON DR
Citation: A. Bork et Dr. Britton, THE WEB IS NOT YET SUITABLE FOR LEARNING, Computer, 31(6), 1998, pp. 115-116

Authors: GRONDIN R BEDARD PJ BRITTON DR SHIOSAKI K
Citation: R. Grondin et al., POTENTIAL THERAPEUTIC USE OF THE SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST, A-86929 - AN ACUTE STUDY IN PARKINSONIAN LEVODOPA-PRIMED MONKEYS, Neurology, 49(2), 1997, pp. 421-426

Authors: MICHAELIDES MR HONG YF DIDOMENICO S BAYBURT EK ASIN KE BRITTON DR LIN CW SHIOSAKI K
Citation: Mr. Michaelides et al., SUBSTITUTED HEXAHYDROBENZO[F]THIENO[C]QUINOLINES AS DOPAMINE D1-SELECTIVE AGONISTS - SYNTHESIS AND BIOLOGICAL EVALUATION IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 40(11), 1997, pp. 1585-1599

Authors: LIN CW BIANCHI BR MILLER TR STASHKO MA WANG SS CURZON P BEDNARZ L ASIN KE BRITTON DR
Citation: Cw. Lin et al., PERSISTENT ACTIVATION OF THE DOPAMINE D-1 RECEPTOR CONTRIBUTES TO PROLONGED RECEPTOR DESENSITIZATION - STUDIES WITH A-77636, The Journal of pharmacology and experimental therapeutics, 276(3), 1996, pp. 1022-1029

Authors: SHIOSAKI K JENNER P ASIN KE BRITTON DR LIN CW MICHAELIDES M SMITH L BIANCHI B DIDOMENICO S HODGES L HONG YF MAHAN L MIKUSA J MILLER T NIKKEL A STASHKO M WITTE D WILLIAMS M
Citation: K. Shiosaki et al., ABT-431 - THE DIACETYL PRODRUG OF A-86929, A POTENT AND SELECTIVE DOPAMINE D-1 RECEPTOR AGONIST - IN-VITRO CHARACTERIZATION AND EFFECTS IN ANIMAL-MODELS OF PARKINSONS-DISEASE, The Journal of pharmacology and experimental therapeutics, 276(1), 1996, pp. 150-160

Authors: SHIOSAKI K ASIN KE BRITTON DR GIARDINA WJ BEDNARZ L MAHAN L MIKUSA J NIKKEL A WISMER C
Citation: K. Shiosaki et al., HYPERACTIVITY AND BEHAVIORAL SEIZURES IN RODENTS FOLLOWING TREATMENT WITH THE DOPAMINE D-1 RECEPTOR AGONISTS A-86929 AND ABT-431, European journal of pharmacology, 317(2-3), 1996, pp. 183-190

Authors: BLANCHET PJ GRONDIN R BEDARD PJ SHIOSAKI K BRITTON DR
Citation: Pj. Blanchet et al., DOPAMINE D-1 RECEPTOR DESENSITIZATION PROFILE IN MPTP-LESIONED PRIMATES, European journal of pharmacology, 309(1), 1996, pp. 13-20

Authors: BRITTON DR JENNER P SMITH L LIN CW MIKUSA J SHIOSAKI K
Citation: Dr. Britton et al., ANTIPARKINSONIAN EFFICACY OF SUBCHRONIC TREATMENT WITH D1 AGONIST, A-86929, The FASEB journal, 9(3), 1995, pp. 394-394

Authors: MICHAELIDES MR HONG YF DIDOMENICO S ASIN KE BRITTON DR LIN CW WILLIAMS M SHIOSAKI K
Citation: Mr. Michaelides et al., HIA-5-AZACYCLOPENT-1-ENA[C]-PHENANTHRENE-9,10-DIOL (A-86929) - A POTENT AND SELECTIVE DOPAMINE D1 AGONIST THAT MAINTAINS BEHAVIORAL EFFICACY FOLLOWING REPEATED ADMINISTRATION AND CHARACTERIZATION OF ITS DIACETYL PRODRUG (ABT-431), Journal of medicinal chemistry, 38(18), 1995, pp. 3445-3447

Authors: BLANCHET P BEDARD PJ BRITTON DR KEBABIAN JW
Citation: P. Blanchet et al., DIFFERENTIAL EFFECT OF SELECTIVE D-1-DOPAMINE AND D-2-DOPAMINE RECEPTOR AGONISTS ON LEVODOPA-INDUCED DYSKINESIA IN METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-EXPOSED MONKEYS, The Journal of pharmacology and experimental therapeutics, 267(1), 1993, pp. 275-279
Risultati: 1-10 |